National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

gemcitabine hydrochloridePatient Information
The hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:difluorodeoxycytidine hydrochloride
gemcitabine
US brand name:Gemzar
Abbreviations:dFdC
dFdCyd
Code name:LY-188011
Chemical structure names:
  • 1-(2-oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose hydrochloride
  • 2'-deoxy-2',2'-difluorocytidine hydrochloride
  • 2'deoxy-2',2'-difluorocytidine hydrochloride



Previous:GD2 lactone/GD3 lactone-KLH conjugate bivalent vaccine, gefitinib, Gelclair, Gelfoam, GEM640
Next:gemcitabine-cisplatin regimen, gemtuzumab ozogamicin, Gemzar, Genasense, Genexol-PM

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov